| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/18/2013 | US20130095089 Glucosylceramide synthase inhibitors and therapeutic methods using the same |
| 04/18/2013 | US20130095087 Absorbable in situ gel-forming system, method of making and use thereof |
| 04/18/2013 | US20130095065 Methods for Treating Vascular Leak Syndrome and Cancer |
| 04/18/2013 | US20130095034 Anti-CD74 Immunoconjugates and Methods |
| 04/18/2013 | US20130095032 Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy |
| 04/18/2013 | CA2852060A1 Polymorphs of arry-380, a selective herb2 inhibitor and pharmaceutical compositions containing them |
| 04/18/2013 | CA2852058A1 Solid dispersion |
| 04/18/2013 | CA2851788A1 Pyrazol-3-ones that activate pro-apoptotic bax |
| 04/18/2013 | CA2851762A1 Antibodies to carcinoembryonic antigen-related cell adhesion molecule (ceacam) |
| 04/18/2013 | CA2851614A1 Compositions useful in treating nephropathy and methods for preparation of same |
| 04/18/2013 | CA2851364A1 8-carbamoyl-2-(2,3-di substituted pyrid-6-yl)-1,2,3,4-tetrahydroisoquinoline derivatives as apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| 04/18/2013 | CA2851284A1 Treatment of breast cancer with companion diagnostic |
| 04/18/2013 | CA2851179A1 A process for making an intermediate of cabazitaxel |
| 04/18/2013 | CA2850830A1 Methods for treating vascular leak syndrome and cancer |
| 04/18/2013 | CA2850575A1 Combination medicament comprising il-12 and an agent for blockade of t-cell inhibitory molecules for tumour therapy |
| 04/18/2013 | CA2850394A1 Indazole compounds as kinase inhibitors and method of treating cancer with same |
| 04/18/2013 | CA2850373A1 Pyrrolobenzodiazepines and targeted conjugates |
| 04/18/2013 | CA2850371A1 Pyrrolobenzodiazepines and conjugates thereof |
| 04/18/2013 | CA2850264A1 Pyrrolobenzodiazepines |
| 04/18/2013 | CA2850103A1 Pyrrolobenzodiazepines |
| 04/18/2013 | CA2850096A1 Synthesis method and intermediates useful in the preparation of pyrrolobenzodiazepines |
| 04/18/2013 | CA2848197A1 Protein kinase inhibitors |
| 04/17/2013 | EP2581451A1 Compounds for inhibiting mammalian s-nitrosoglutathione reductase |
| 04/17/2013 | EP2581380A1 Sialic acid ( -(2 6)-d-aminopyranose derivatives, synthesis methods and uses thereof |
| 04/17/2013 | EP2581373A1 Benzo- or pyrido-imidazole derivative |
| 04/17/2013 | EP2581372A1 Cyanoquinoline derivatives |
| 04/17/2013 | EP2581371A1 Pyrrolyl substituted dihydroindol-2-one derivatives, preparation methods and uses thereof |
| 04/17/2013 | EP2581370A1 Crystals of di(arylamino)aryl compound |
| 04/17/2013 | EP2581367A2 Salts of isophosphoramide mustard and analogs thereof |
| 04/17/2013 | EP2581084A1 Solid dispersion comprising triazole compound |
| 04/17/2013 | EP2581083A1 Methods of treating hematologic cancers using pnp inhibitors such as forodesine in combination with alkylating agents or anti-cd20 agents |
| 04/17/2013 | EP2580240A1 S100a4 antibodies and therapeutic uses thereof |
| 04/17/2013 | EP2580239A1 Treating cancer by modulating mammalian sterile 20-like kinase 3 |
| 04/17/2013 | EP2580221A1 Crystalline forms of kinase inhibitors |
| 04/17/2013 | EP2580220A1 Crystalline forms of kinase inhibitors |
| 04/17/2013 | EP2580219A1 Crystalline forms of kinase inhibitors |
| 04/17/2013 | EP2580210A2 Estrogen receptor modulators and uses thereof |
| 04/17/2013 | EP2580207A1 Nitrogen containing heteroaryl compounds |
| 04/17/2013 | EP2580206A2 Pharmaceutical composition comprising amide derivative or pharmaceutically acceptable salt thereof |
| 04/17/2013 | EP2579885A1 Parvovirus for treatment of tumours by intranasal application |
| 04/17/2013 | EP2579884A1 Anti-tumor composition |
| 04/17/2013 | EP2579878A1 Methods of treating hematological disorders with quinazolinone compounds in selected patients |
| 04/17/2013 | EP2579877A1 Morpholino pyrimidines and their use in therapy |
| 04/17/2013 | EP2494956A9 Paclitaxel/steroidal complex |
| 04/17/2013 | CN202875845U Cancer-preventing/treating and anti-aging tablet structure |
| 04/17/2013 | CN1917899B Use of alkaline phosphatase for the detoxification of lps |
| 04/17/2013 | CN1604788B High-concentration protein formulations and method of manufacture |
| 04/17/2013 | CN103052882A Method for screening chronic inflammation suppression agent or cancer metastasis suppression agent having inhibition of bonding of emmprin and s100a9 as indicator |
| 04/17/2013 | CN103052642A Crystal of tricyclic pyrazolopyrimidine derivative |
| 04/17/2013 | CN103052641A Novel fused heterocyclic derivatives useful as C-Met tyrosine kinase inhibitors |
| 04/17/2013 | CN103052633A Amids Substituted Indazole Derivativees As Ploy(adp-ribose)polymerase Inhibitors |
| 04/17/2013 | CN103052627A Pyrimidine derivatives as fak inhibitors |
| 04/17/2013 | CN103052404A Neuropilin as a biomarker for bevacizumab combination therapies |
| 04/17/2013 | CN103052403A Treating Disorders Associated With IL-20 Receptor-mediated Signaling Pathway By Blocking IL-20 Receptor Activity |
| 04/17/2013 | CN103052391A Pyrroloquinoline quinone gel |
| 04/17/2013 | CN103052386A Composition containing tetracyclic compound |
| 04/17/2013 | CN103052385A Methods of treatment of hepatocellular carcinoma |
| 04/17/2013 | CN103045715A Medicament target for treating acute promyelocytic leukemia and inhibitor thereof |
| 04/17/2013 | CN103045634A Cationic liposome compound of cancer suppressor gene LKB1 eukaryotic expression plasmid as well as preparation method and anti-tumor effect thereof |
| 04/17/2013 | CN103045595A Antisense oligonucleotide for restraining expression of human hPEBP4 (Phosphatidyl Ethanolamine Binding Family Protein) gene and application thereof |
| 04/17/2013 | CN103044556A Recombined fusion protein VIP-TAT and application thereof |
| 04/17/2013 | CN103044555A Fused protein containing cFms extracellular fragments, preparation method and applications of fused protein with cFms extracellular fragments |
| 04/17/2013 | CN103044554A Human urinary trypsin inhibitor (hUTI) of reorganization-dimerization and preparation method and application thereof |
| 04/17/2013 | CN103044552A Humanized monoclonal antibody for resisting DEC-205 molecules on surface of dendritic cells |
| 04/17/2013 | CN103044547A Anti-humanized multidrug resistant protein Fab antibody and preparation method thereof |
| 04/17/2013 | CN103044542A Serine protease inhibitor in crucian egg as well as gene and application thereof |
| 04/17/2013 | CN103044522A Polypeptide having high affinity with receptor of integrin alpha v beta3 |
| 04/17/2013 | CN103044521A Aspartase-targeted activated adriamycin derivative as well as preparation method and application thereof |
| 04/17/2013 | CN103044518A 3-oxo-7-oximido-4-aza-A-homo-chenodeoxycholic acid methyl ester and 3-O-benzyl oximido-7-aza-7a-oxo-B-homo-chenodeoxycholic acid methyl ester, and application of 3-oxo-7-oximido-4-aza-A-homo-chenodeoxycholic acid methyl ester and 3-O-benzyl oximido-7-aza-7a-oxo-B-homo-chenodeoxycholic acid methyl ester in preparing antineoplastic drug |
| 04/17/2013 | CN103044514A Preparation method of 3beta-hydroxy-6-thiosemicarbazone steroid metal complex and application of metal complex in antineoplastic drug |
| 04/17/2013 | CN103044483A Triphenyltin (IV) coordination compound and preparation method and application thereof |
| 04/17/2013 | CN103044482A Dibutyltin coordination compound and preparation method and application thereof |
| 04/17/2013 | CN103044477A Trimethyl silicon substituted benzopyran compound and application thereof |
| 04/17/2013 | CN103044460A 3,5,7-triphenyl-5H-thiazolo[3,2-a]pyrimidin derivatives and application thereof |
| 04/17/2013 | CN103044446A Heterocycle quinoline derivatives as well as medicinal salts, preparation method and medicinal application thereof |
| 04/17/2013 | CN103044437A Amphiphilic conjugate nano-particle for treating tumors, as well as preparation method and application of same |
| 04/17/2013 | CN103044432A 双环杂芳基化合物 Bicyclic heteroaryl compounds |
| 04/17/2013 | CN103044423A Substituted pyridine-2-ketone compounds and preparation method thereof |
| 04/17/2013 | CN103044420A Phenanthroline derivative, as well as preparation method and application thereof |
| 04/17/2013 | CN103044408A Itraconazole applied to treatment of malignant tumor or salt thereof and composition thereof |
| 04/17/2013 | CN103044395A Desloratadine-containing amino acid derivative as well as preparation method and application thereof |
| 04/17/2013 | CN103044394A Phenyl aminopyrimidine derivant and preparation method and application thereof |
| 04/17/2013 | CN103044392A Preparation method of high-efficient DPP (dipeptidyl peptidase)-IV inhibitor |
| 04/17/2013 | CN103044391A High-efficient DPP (dipeptidyl peptidase)-IV inhibitor |
| 04/17/2013 | CN103044364A Cabazitaxel amorphous crystal and preparation method thereof |
| 04/17/2013 | CN103044363A Paclitaxel derivative as well as preparation method and application thereof |
| 04/17/2013 | CN103044350A Preparation of 1,3,4-oxadiazole compounds and application thereof in anticancer treatment drug |
| 04/17/2013 | CN103044341A 1, 2, 3-triazole-dithiocarbamate-urea complex, as well as preparation method and application thereof |
| 04/17/2013 | CN103044338A miR-2 small molecule and application |
| 04/17/2013 | CN103044335A Synthesis method of 3-benzyl-1-(3-methoxy benzyl)-2,4,5-trimethylimidazole chloride |
| 04/17/2013 | CN103044326A 5-bromo oxoisoaporphine, and synthesis method and application thereof |
| 04/17/2013 | CN103044325A Anti-breast cancer application of indeno isoquinoline estrogen receptor alpha regulator |
| 04/17/2013 | CN103044311A Multi-substituted indole compounds and preparation method and application thereof |
| 04/17/2013 | CN103043635A Drug-resistant cisplatin mineralization liquid and preparation method and application thereof |
| 04/17/2013 | CN103041405A Diagnosis-treatment integrative medicine carrying polymer and preparation method thereof |
| 04/17/2013 | CN103041403A Glucan-containing pharmaceutical composition and preparation method thereof |
| 04/17/2013 | CN103041402A Antitumoral bioconjugates of hyaluronic acid or its derivatives obtained by indirect chemical conjugation |
| 04/17/2013 | CN103041401A Targeted anti-bladder-cancer albumin carrying mitomycin drug and preparation method thereof |
| 04/17/2013 | CN103041387A New application of malignant B-cell lymphoma antibody medicament |
| 04/17/2013 | CN103041317A Traditional Chinese medicine composition for treating tumors and preparation method thereof |